Bacterial enteritis has long been recognized as a serious threat to animal health and production economics around the world. Since 2000, Elanco has been keeping tabs on this issue through a series of global surveys conducted every five years. Called the Bacterial Enteritis Global Impact Assessment (BEGIA), the 2015 survey responses reconfirm that bacterial enteritis is still a critical threat to Intestinal Integrity.
- Concerns include increased mortality, negative effects on animal well-being, impaired feed conversion and weight gain, and increased condemnations at processing. Early preventive treatment/interventions that align with responsible use of antibiotics are becoming more essential to overcome these challenges. In the U.S., more than 60% of survey respondents reported diagnosed bacterial enteritis in the flocks and believe bacterial enteritis will remain the same or worsen during the next five years.
- More than 85% found prevalence and severity of bacterial enteritis increase when coccidiosis is present.
- 93% reported some performance losses caused by bacterial enteritis, costing up to $0.05 per bird, or $50,000 for every 1 million birds.
Almost half of the respondents also noted that they believe the negative economic impact begins at the earliest stages of the disease and treatment should be initiated at this stage. Continuing to manage Intestinal Integrity in the face of increased global competition will be key in managing bird health and profitability.
Elanco and the diagonal bar logo are trademarks owned or licensed by Eli Lilly and Company or affiliates.